Diabetic maculopathy : Diagnosis and treatment.

13:35 EDT 17th September 2014 | BioPortfolio

Summary of "Diabetic maculopathy : Diagnosis and treatment."

Due to demographic change the incidence of diabetic retinopathy has risen in spite of new facilities and prevention campaigns and is still one of the leading causes of blindness in Germany. The combination of focal/grid laser photocoagulation and an intravitreal anti-VEGF (vascular endothelial growth factor) regimen is the first line approach for clinically significant macular edema with foveal involvement and is evidence-based. Vitreomacular interface abnormalities can be effectively treated by modern vitreomacular surgery. Unfortunately, no proven treatment modality can be provided for ischemic maculopathy. The management of systemic risks factors, such as hyperglycemia and arterial hypertension, remains a task of great importance despite all modifications and increase of knowledge during recent years. Innovative developments in the field of intravitreal pharmacotherapy have opened up new vistas. There are good prospects that modern ophthalmology will not be limited to preserving visual function but to allow improvements and consequently enhance health-related quality of life for diabetic patients.

Affiliation

Abteilung für Augenheilkunde, Eberhard-Karl-Universität Tübingen, Schleichstrasse 12, 72076, Tübingen, Deutschland, Faik.Gelisken@med.uni-tuebingen.de.

Journal Details

This article was published in the following journal.

Name: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
ISSN: 1433-0423
Pages:

Links

PubMed Articles [24289 Associated PubMed Articles listed on BioPortfolio]

The Diagnostic Function of OCT in Diabetic Maculopathy.

Diabetic maculopathy (DM) is one of the major causes of vision impairment in individuals with diabetes. The traditional approach to diagnosis of DM includes fundus ophthalmoscopy and fluorescein angio...

Management of diabetic retinopathy and diabetic maculopathy in elderly patients with diabetes mellitus.

The world's population is aging, and simultaneously, the prevalence of diabetes mellitus worldwide is rapidly increasing. Therefore, the clinical management of diabetic retinopathy and diabetic maculo...

Incidence of Retinal Complications in a Cohort of Newly Diagnosed Diabetic Patients.

We aimed at estimating the incidence of diabetic retinopathy (DR) and maculopathy (DMP) among newly diagnosed type 1 (t1DM) and type 2 diabetic patients (t2DM) in the United Kingdom primary care syste...

Treatment of hyperglycemia in newly diagnosed diabetic patients is associated with a reduction in oxidative stress and improvement in β-cell function.

There exist several reports demonstrating enhancement in oxidative stress (OS) in diabetic patients, however, serial and comprehensive measurement of oxidative stress parameters (OSP) in newly diagnos...

Pathogenesis and Treatment of Maculopathy Associated with Cavitary Optic Disc Anomalies.

To propose a unifying theory regarding the pathogenesis of maculopathy associated with cavitary optic disc anomalies and describe a rational approach to achieving a permanent cure in affected eyes.

Clinical Trials [2227 Associated Clinical Trials listed on BioPortfolio]

Prophylactic Laser Treatment of Drusen Maculopathy

To study the effect of mild laser treatment on the incidence of exudative complications in soft drusen maculopathy. We hypothesise that mild laser treatment causing a proliferation of the ...

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy

To assess the use of Avastin for the management of serosanguinous maculopathy

Characteristics of Non Diabetic Hyperglycemic Inpatients

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with - hyperglycemia on admission b...

Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser

This study compares the use of intravitreous triamcinolone and laser therapy to treat maculopahty in patients with type 2 diabetes mellitus in a short-tem period of 6 months

Hyperbaric Oxygen Therapy and Angiogenesis in Diabetic Patients With Foot Ulcers

Diabetic foot ulcers are a major cause of morbidity and mortality, accounting for approximately two-thirds of all non-traumatic amputations performed in the United States. The cost of foot...

Medical and Biotech [MESH] Definitions

Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)

Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.

A diet prescribed in the treatment of diabetes mellitus, usually limited in the amount of sugar or readily available carbohydrate. (Dorland, 27th ed)

Common foot problems in persons with DIABETES MELLITUS, caused by any combination of factors such as DIABETIC NEUROPATHIES; PERIPHERAL VASCULAR DISEASES; and INFECTION. With the loss of sensation and poor circulation, injuries and infections often lead to severe foot ulceration, GANGRENE and AMPUTATION.

A system for classifying patient care by relating common characteristics such as diagnosis, treatment, and age to an expected consumption of hospital resources and length of stay. Its purpose is to provide a framework for specifying case mix and to reduce hospital costs and reimbursements and it forms the cornerstone of the prospective payment system.

Search BioPortfolio:
Loading